Ms. Schena: Arrayit Corp. is a newly public company as of March 2009. We find our roots as a subsidiary of TeleChem International, Inc., which was founded in 1993 by myself and Todd Martinsky, our Executive VP. We have been pioneers in the microarray marketplace, being one of the very earliest companies in this space, starting in 1997. We have some patented technology, and obviously a lot of trade-secret and other technology that we've developed over the past 13 years, the most important being our printing technology.
TWST: Let's talk about what exactly microarray technology is, if you would.
Dr. Schena: A microarray is a tiny device that contains nearly invisible spots of DNA, protein and other molecules found in the human body, and those spots are arranged in rows and columns on a glass substrate. And microarray devices allow scientists and doctors to explore pathways in the human body with very high precision and high specificity, and allow, for example, the detection of diseases on a pre-symptomatic basis. So essentially you could think of a microarray as a high-tech biological computer chip. It's a device that processes medical information with very high speed and high precision.
Tickers included in this excerpt: ARYC
For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.